Pelthos Therapeutics (PTHS)
Commercializes topical treatments for molluscum, impetigo, and head lice.
$25.91
Pre-market+0.89 (+3.56%)
At close$25.02(+0.81%)
Something off on this page? Send us feedback.
Next report
Nov 12, 2026
in 70 days
EPS estimate
−$2.90
Revenue estimate
$18.0M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$3.23−$3.21−$5.38−$5.30−$6.87−$3.09−$6.62Pending
Estimate—−$2.90−$5.82−$0.67−$3.95−$3.45−$2.82−$2.90
Surprise—−10.7%+7.6%−691.0%−73.9%+10.4%−134.8%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported—$150.0K—$7.4M$9.4M$10.9M$15.6MPending
Estimate——$4.4M$4.4M$9.1M$10.4M$15.2M$18.0M
Surprise———+68.7%+3.3%+4.5%+2.8%—
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$2.90 | — | — |
| Aug 2026 | −$2.82 | −$6.62 | −134.8% |
| May 2026 | −$3.45 | −$3.09 | +10.4% |
| Mar 2026 | −$3.95 | −$6.87 | −73.9% |
| Nov 2025 | −$0.67 | −$5.30 | −691.0% |
The latest year is open to everyone — the 6 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 12, 2026 | −$2.90 | — | — | $18.0M | — | — | — |
| Aug 13, 2026 | −$2.82 | −$6.62 | −134.8% | $15.2M | $15.6M | +2.8% | +0.1% |
| May 14, 2026 | −$3.45 | −$3.09 | +10.4% | $10.4M | $10.9M | +4.5% | −3.5% |
| Mar 19, 2026 | −$3.95 | −$6.87 | −73.9% | $9.1M | $9.4M | +3.3% | −9.7% |
| Nov 13, 2025 | −$0.67 | −$5.30 | −691.0% | $4.4M | $7.4M | +68.7% | −3.1% |
The latest year is open to everyone — the 6 quarters behind it read with an account. Sign in | |||||||
| Aug 13, 2025 | |||||||
| May 13, 2025 | |||||||
| Mar 27, 2025 | |||||||
| Nov 13, 2024 | |||||||
| Aug 13, 2024 | |||||||
| May 15, 2024 | |||||||